Alivus Life Sciences P/B Ratio
ALIVUS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
3.66
High Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
3.66
Current Price
₹906.85
Book Value/Share
₹1126.80
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹2,817 Cr
Share Capital
₹25 Cr
Reserves & Surplus
₹2,793 Cr
Outstanding Shares
25,000,000
Book Value per Share
₹1126.80
Valuation Signal
Signal
Overvalued
Historical Avg
0.66
Historical Range
0.17 - 1.05
Percentile
100.0%
Sector Context
Sector Average
-0.09
Sector Median
0.65
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Alivus Life Sciences
- Stock appears overvalued with PB of 3.66, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 452.9% above historical average
- Trading at premium to sector average PB of -0.09
View the current stock price of Alivus Life Sciences for more insights.
P/B Ratio Historical Trend for Alivus Life Sciences
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Alivus Life Sciences
Additional stock information and data for ALIVUS
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.81 | ₹1126.8 | ₹916.60 | ₹2,817 | Low |
| 2024 | 1.05 | ₹932.8 | ₹983.45 | ₹2,332 | Moderate |
| 2023 | 0.77 | ₹855.2 | ₹657.05 | ₹2,138 | Low |
| 2022 | 0.51 | ₹821.6 | ₹420.15 | ₹2,054 | Low |
| 2021 | 0.17 | ₹3765.0 | ₹631.05 | ₹753 | Low |
Sector P/B Ratio Comparison
Comparing Alivus Life Sciences with other companies in Healthcare sector
Sector Average
-0.09
Sector Median
0.65
Lowest P/B
-12.71
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.71 | ₹4,389 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.27 | ₹57 | Low |